Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Pharmaceutical packaging has evolved from a simple protective shell into a sophisticated tool for safety, adherence, and anti ...

Merck beats Q1 2025 estimates despite Gardasil sales drop, driven by Vaxneuvance, Winrevair & Welireg. Click here to find out ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The Midas List returns for its 24th year with another definitive ranking of the 100 best tech investors in the world.

Understand Ipsen’s competitive environment and the macro factors that have shaped the pharma industry and will influence its future evolution. Explore the need for a mid-sized global pharma to design ...

US stocks dive; Rio Tinto seeks successor to Stausholm; Wesfarmers warns on lithium losses; Lynas gets double upgrade; gold ...

Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come ...